The resulting comprehensive report was published in April 2019 and acts as a persuasive call to action. The Lown Institute was equipped to engage a wide audience of pharmacies, clinicians and clinician specialty groups, patients, patient advocacy groups, and families/caregivers in order to communicate the message of harmful polypharmacy and create a sense of urgency to get the public involved.